PUBLISHER: Grand View Research | PRODUCT CODE: 1446459
PUBLISHER: Grand View Research | PRODUCT CODE: 1446459
The global intracranial aneurysm market size is anticipated to reach USD 2.33 billion by 2030, registering a CAGR of 9.08% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to various factors, such as increased cases of stroke, increasing incidence of people suffering from cerebrovascular disorders, and continuous product launches by key players. Furthermore, the market is growing rapidly in developing nations with expanding disposable income levels and improved access to healthcare. Currently, the cause of brain aneurysms is not clearly understood. However, there are various factors linked to this condition, including aging, brain trauma, hereditary, high blood pressure, atherosclerosis, infections, and a sedentary lifestyle. Notable symptoms encompass cranial nerve dysfunction, localized headaches, and double vision.
Consequently, the growing population of individuals afflicted with intracranial aneurysms is contributing to the market expansion. Businesses in this field are always looking for ways to make existing therapies safer and more effective while also introducing new technologies, which are anticipated to increase the demand for intracranial aneurysm products globally. For instance, in June 2022, Pipeline Vantage with Shield Technology, a fourth-generation flow deflector with a CE mark by India Medtronic, was developed for endovascular therapy for cerebral aneurysms. A newly developed flow deflector, Pipeline Vantage, features Shield technology and has enhanced features of the design for both the delivery system and the implant. By developing a scaffold that promotes the development of cells in the innermost layer of the target blood vessel, these qualities make it easier and more reliable for doctors to deliver, deploy, and repair brain aneurysms and intracranial aneurysms.